The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Regulatory News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,357.00
Bid: 1,343.00
Ask: 1,347.00
Change: 29.00 (2.18%)
Spread: 4.00 (0.298%)
Open: 1,331.00
High: 1,358.00
Low: 1,299.00
Prev. Close: 1,328.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

17 Nov 2023 10:00

RNS Number : 8389T
Indivior PLC
17 November 2023

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BN4HT335

Issuer Name

INDIVIOR PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of financial instruments

3. Details of person subject to the notification obligation

Name

The Goldman Sachs Group, Inc.

City of registered office (if applicable)

Wilmington, Delaware

Country of registered office (if applicable)

USA

4. Details of the shareholder

Name

City of registered office

Country of registered office

Goldman Sachs International

London

United Kingdom

5. Date on which the threshold was crossed or reached

14-Nov-2023

6. Date on which Issuer notified

16-Nov-2023

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

0.150099

4.998967

5.149066

7102581

Position of previous notification (if applicable)

0.042726

5.022807

5.065533

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BN4HT335

207046

0.150099

Sub Total 8.A

207046

0.150099%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Securities Lending

Open

6413639

4.649614

Sub Total 8.B1

6413639

4.649614%

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Swap

05-Sep-2033

Cash

249929

0.181188

Swap

28-Feb-2033

Cash

84481

0.061245

Swap

10-Nov-2033

Cash

72897

0.052847

Swap

23-May-2033

Cash

22558

0.016353

Swap

10-Oct-2033

Cash

18211

0.013202

Swap

16-May-2033

Cash

16129

0.011693

Swap

16-Nov-2026

Cash

6800

0.004930

Swap

15-Nov-2027

Cash

3343

0.002423

Swap

25-Oct-2033

Cash

2155

0.001563

Swap

14-Nov-2033

Cash

2094

0.001518

Swap

22-Sep-2033

Cash

1656

0.001200

Swap

28-Feb-2033

Cash

1161

0.000841

Swap

29-Jan-2030

Cash

231

0.000167

Swap

14-Nov-2033

Cash

179

0.000130

Swap

26-Oct-2026

Cash

56

0.000041

Swap

14-Nov-2033

Cash

16

0.000012

Sub Total 8.B2

481896

0.349353%

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

The Goldman Sachs Group, Inc. (Chain 1)

The Goldman Sachs Group, Inc. (Chain 1)

Goldman Sachs (UK) L.L.C.

0.108136

4.990824

5.098960%

The Goldman Sachs Group, Inc. (Chain 1)

Goldman Sachs Group UK Limited

0.108136

4.990824

5.098960%

The Goldman Sachs Group, Inc. (Chain 1)

Goldman Sachs International

0.108136

4.990824

5.098960%

The Goldman Sachs Group, Inc. (Chain 2)

The Goldman Sachs Group, Inc. (Chain 2)

GSAM Holdings LLC

The Goldman Sachs Group, Inc. (Chain 2)

Goldman Sachs Asset Management, L.P.

The Goldman Sachs Group, Inc. (Chain 3)

The Goldman Sachs Group, Inc. (Chain 3)

Folio Financial, Inc.

The Goldman Sachs Group, Inc. (Chain 3)

Folio Investments Inc.

The Goldman Sachs Group, Inc. (Chain 4)

The Goldman Sachs Group, Inc. (Chain 4)

The Goldman Sachs Group, Inc.

The Goldman Sachs Group, Inc. (Chain 4)

Goldman Sachs Bank USA

The Goldman Sachs Group, Inc. (Chain 4)

Goldman Sachs Bank Europe SE

The Goldman Sachs Group, Inc. (Chain 5)

The Goldman Sachs Group, Inc. (Chain 5)

Goldman Sachs & Co. LLC

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

Please note, the total amount of voting rights have been rounded to 6 decimal places therefore there is a possibility of a rounding error. General email contact: gs-regops-emea-position-enquiries@gs.com

12. Date of Completion

16-Nov-2023

13. Place Of Completion

Warsaw

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
HOLFFMSUWEDSEIF
Date   Source Headline
10th Jul 20234:00 pmRNSHolding(s) in Company
5th Jul 20234:00 pmRNSHolding(s) in Company
30th Jun 20234:00 pmRNSDirector Declaration
29th Jun 20234:00 pmRNSHolding(s) in Company
27th Jun 202311:00 amRNSNotice of Results
21st Jun 20234:00 pmRNSHolding(s) in Company
16th Jun 20234:00 pmRNSHolding(s) in Company
15th Jun 20234:00 pmRNSHolding(s) in Company
14th Jun 20234:00 pmRNSHolding(s) in Company
14th Jun 20234:00 pmRNSHolding(s) in Company
13th Jun 20234:00 pmRNSHolding(s) in Company
12th Jun 20237:00 amRNSIndivior to Commence Trading on Nasdaq
7th Jun 20233:45 pmRNSHolding(s) in Company
2nd Jun 20235:17 pmRNSIndivior settles antitrust MDL with states and DC
1st Jun 20239:11 amRNSTotal Voting Rights
26th May 20234:20 pmRNSHolding(s) in Company
25th May 20232:30 pmRNSIndivior to Participate in Upcoming Conferences
24th May 20233:05 pmRNSHolding(s) in Company
23rd May 20236:05 pmRNSIndivior Files Form 20-F for US Listing
23rd May 20232:42 pmRNSHolding(s) in Company
23rd May 20238:30 amRNSHolding(s) in Company
23rd May 20237:00 amRNSUS FDA Approves OPVEE
12th May 20232:56 pmRNSHolding(s) in Company
10th May 20233:30 pmRNSDirector/PDMR Shareholding
10th May 202312:00 pmRNSBlock listing Interim Review
10th May 20238:51 amRNSHolding(s) in Company
4th May 20232:48 pmRNSResult of AGM
27th Apr 202312:00 pmRNS1st Quarter Results
25th Apr 20232:30 pmRNSIndivior to Participate in Conference
25th Apr 20239:26 amRNSHolding(s) in Company
20th Apr 20238:43 amRNSHolding(s) in Company
18th Apr 20238:09 amRNSHolding(s) in Company
17th Apr 20234:25 pmRNSHolding(s) in Company
11th Apr 20232:00 pmRNSNotice of Q1 Results
6th Apr 202312:24 pmRNSHolding(s) in Company
3rd Apr 20239:35 amRNSTotal Voting Rights
30th Mar 20232:37 pmRNSHolding(s) in Company
28th Mar 20233:21 pmRNSHolding(s) in Company
27th Mar 202311:42 amRNSAnnual Financial Report
24th Mar 20232:30 pmRNSDirector/PDMR Shareholding
23rd Mar 202310:02 amRNSBlock Listing of Shares
22nd Mar 20233:00 pmRNSDirector/PDMR Shareholding
16th Mar 20232:30 pmRNSDirector/PDMR Shareholding
15th Mar 20232:30 pmRNSDirector/PDMR Shareholding
13th Mar 20234:04 pmRNSDirector/PDMR Shareholding
13th Mar 20232:36 pmRNSHolding(s) in Company
8th Mar 20239:42 amRNSDirector/PDMR Shareholding
6th Mar 20234:00 pmRNSDirector/PDMR Shareholding
6th Mar 202310:21 amRNSHolding(s) in Company
2nd Mar 20231:56 pmRNSIndivior Completes Opiant Transaction

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.